Zheng‐Rong Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zheng‐Rong Lu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Anagha Vaidya
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah , USA
1 shared publicationEun‐Kee Jeong
Department of Radiology, University of Utah, Salt Lake City, Utah
1 shared publicationTianyi Ke
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah
1 shared publicationYongen Sun
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah
1 shared publication
Latest Publications
- Open Access
- 10 August 2006
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 56 (4) , 761-767
Contrast enhanced MRI‐guided photodynamic therapy for site‐specific cancer treatment
Photodynamic therapy (PDT) is a minimally invasive and effective approach for cancer treatment. It is potentially useful for treating tumors that are not accessible to surgery, radiation, or destructive ablations, and are resistant to chemotherapy. Efficacious treatment of interstitial tumors with PDT requires efficient delivery of photosensitizers and accurate location of tumor tissues for effective light irradiations. In this study we performed contrast‐enhanced (CE) MRI‐guided PDT with a bifunctional polymer conjugate containing both a magnetic resonance imaging (MRI) contrast agent and a photosensitizer, poly(L‐glutamic acid) (PGA)‐(Gd‐DO3A)‐mesochlorin e6 (Mce6). The efficacy of the bifunctional conjugate in cancer CE‐MRI and cancer treatment was evaluated in athymic nude mice bearing MDA‐MB‐231 human breast carcinoma xenografts, with PGA‐(Gd‐DO3A) used as a control. The polymer conjugates preferentially accumulated in the solid tumor due to the hyperpermeability of the tumor vasculature, resulting in significant tumor enhancement for accurate tumor detection and localization by MRI. Significant therapeutic response was observed for PDT with the bifunctional conjugate as compared to the control. CE‐MRI‐guided PDT with the bifunctional conjugate is effective for tumor detection and minimally invasive cancer treatment. Magn Reson Med, 2006.
- 10 August 2006
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 56 (4) , 761-767
Open AccessContrast enhanced MRI‐guided photodynamic therapy for site‐specific cancer treatment
Photodynamic therapy (PDT) is a minimally invasive and effective approach for cancer treatment. It is potentially useful for treating tumors that are not accessible to surgery, radiation, or destructive ablations, and are resistant to chemotherapy. Efficacious treatment of interstitial tumors with PDT requires efficient delivery of photosensitizers and accurate location of tumor tissues for effective light irradiations. In this study we performed contrast‐enhanced (CE) MRI‐guided PDT with a bifunctional polymer conjugate containing both a magnetic resonance imaging (MRI) contrast agent and a photosensitizer, poly(L‐glutamic acid) (PGA)‐(Gd‐DO3A)‐mesochlorin e6 (Mce6). The efficacy of the bifunctional conjugate in cancer CE‐MRI and cancer treatment was evaluated in athymic nude mice bearing MDA‐MB‐231 human breast carcinoma xenografts, with PGA‐(Gd‐DO3A) used as a control. The polymer conjugates preferentially accumulated in the solid tumor due to the hyperpermeability of the tumor vasculature, resulting in significant tumor enhancement for accurate tumor detection and localization by MRI. Significant therapeutic response was observed for PDT with the bifunctional conjugate as compared to the control. CE‐MRI‐guided PDT with the bifunctional conjugate is effective for tumor detection and minimally invasive cancer treatment. Magn Reson Med, 2006.